Literature DB >> 25750291

miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.

Koichi Yoneyama1, Osamu Ishibashi2, Rieko Kawase3, Keisuke Kurose3, Toshiyuki Takeshita3.   

Abstract

Endometrioid endometrial carcinoma (EEC) is a common malignancy of the female genital tract. However, no adequate biomarker is currently available for predicting the prognosis of this cancer. Recent studies have revealed dysregulated expression of several microRNAs (miRNAs) in various cancer tissues, and therefore, these cancer-associated miRNAs (also called onco-miRs) could be promising prognostic biomarkers of cancer progression or metastasis. In this study, in order to identify onco-miRs and their possible targets involved in EEC, we performed microarray-based integrative analyses of miRNA and mRNA expression in specimens excised from EEC lesions and adjacent normal endometrial tissues. Using integrated statistical analyses, we identified miR-200a, miR-200b and miR-429 as highly up-regulated onco-miRs in EECs. Conversely, we detected expression of a tumor-suppressor gene, phosphatase and tensin homolog (PTEN), which was predicted in silico using a miRNA-targeting mRNA prediction algorithm, as a target of the three miRNAs and which was down-regulated in EECs. Furthermore, these miRNAs were validated to target PTEN experimentally using luciferase assays and real-time polymerase chain reaction. These results suggest that the occurrence of EEC is, at least in part, mediated by miRNA-induced suppression of PTEN expression. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Endometrioid endometrial cancer; PTEN; microRNA

Mesh:

Substances:

Year:  2015        PMID: 25750291

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  25 in total

1.  miR-429 mediates tumor growth and metastasis in colorectal cancer.

Authors:  Yantao Han; Qian Zhao; Jie Zhou; Rui Shi
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

2.  Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer.

Authors:  Beata Rak; Dawid Mehlich; Filip Garbicz; Zofia Domosud; Wiktor Paskal; Janina M Marczewska; Paweł K Włodarski
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

Review 3.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

4.  miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.

Authors:  Gang Peng; Yiwei Liao; Chenfu Shen
Journal:  Pathol Oncol Res       Date:  2016-09-23       Impact factor: 3.201

5.  Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer.

Authors:  Nouha Setti Boubaker; Aymone Gurtner; Nesrine Trabelsi; Isabella Manni; Haroun Ayed; Ahmed Saadi; Zeineb Naimi; Meriem Ksontini; Mouna Ayadi; Ahlem Blel; Soumaya Rammeh; Mohamed Chebil; Giulia Piaggio; Slah Ouerhani
Journal:  Mol Biol Rep       Date:  2020-10-31       Impact factor: 2.316

6.  miR-429 promotes the proliferation of non-small cell lung cancer cells via targeting DLC-1.

Authors:  Peng Xiao; Wenliang Liu; Hui Zhou
Journal:  Oncol Lett       Date:  2016-07-22       Impact factor: 2.967

7.  IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.

Authors:  Jie-Mei Wang; Yining Qiu; Zhao Yang; Hyunbae Kim; Qingwen Qian; Qinghua Sun; Chunbin Zhang; Lei Yin; Deyu Fang; Sung Hong Back; Randal J Kaufman; Ling Yang; Kezhong Zhang
Journal:  Sci Signal       Date:  2018-05-15       Impact factor: 8.192

8.  Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.

Authors:  Shweta Sharma; Showket Hussain; Kartik Soni; Pallavi Singhal; Richa Tripathi; V G Ramachandran; Sonal Sharma; Shukla Das; Beena Pillai; Mausumi Bharadwaj
Journal:  Tumour Biol       Date:  2015-10-27

9.  MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.

Authors:  Xiaomeng Zhao; Lili Dai; Qifang Yue; Hua Wang; X U Wang; Yuan Li; Ran Chen
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

10.  Expression and Clinical Pathological Significance of miR-200a in Concurrent Cholangiocarcinoma Associated with Hepatolithiasis.

Authors:  Chen Chen; Dinghua Yang; Qunwei Wang; Xintian Wang
Journal:  Med Sci Monit       Date:  2015-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.